Proteasome inhibitor carfilzomib interacts synergistically with histone deacetylase inhibitor vorinostat in Jurkat T-leukemia cells.
about
Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cellsSynergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2.Regulation rewiring analysis reveals mutual regulation between STAT1 and miR-155-5p in tumor immunosurveillance in seven major cancers.Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma.Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma.Dihydrocelastrol inhibits multiple myeloma cell proliferation and promotes apoptosis through ERK1/2 and IL-6/STAT3 pathways in vitro and in vivo.
P2860
Proteasome inhibitor carfilzomib interacts synergistically with histone deacetylase inhibitor vorinostat in Jurkat T-leukemia cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Proteasome inhibitor carfilzom ...... at in Jurkat T-leukemia cells.
@en
Proteasome inhibitor carfilzom ...... at in Jurkat T-leukemia cells.
@nl
type
label
Proteasome inhibitor carfilzom ...... at in Jurkat T-leukemia cells.
@en
Proteasome inhibitor carfilzom ...... at in Jurkat T-leukemia cells.
@nl
prefLabel
Proteasome inhibitor carfilzom ...... at in Jurkat T-leukemia cells.
@en
Proteasome inhibitor carfilzom ...... at in Jurkat T-leukemia cells.
@nl
P2093
P50
P356
P1476
Proteasome inhibitor carfilzom ...... tat in Jurkat T-leukemia cells
@en
P2093
Guang Yang
Hongwei Xu
Minjie Gao
Xiaosong Wu
P304
P356
10.1093/ABBS/GMU030
P577
2014-05-06T00:00:00Z